Cytomegalovirus: Should we screen pregnant women for primary infection?

American Journal of Perinatology

Volumn 30, Issue 2, 2013, Pages 121-124

  Johnson, Julie M ^a   Anderson, Brennal ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

CMV hyperimmune globulin; congenital cytomegalovirus; primary CMV infection; screening program

Indexed keywords

HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY;

BINDING AFFINITY; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; HYGIENE; IMMUNOCOMPETENCE; INFECTION RISK; MEDICAL LITERATURE; PREGNANT WOMAN; PREVALENCE; PRIMARY INFECTION; PRIORITY JOURNAL; REVIEW; SCREENING; SEROCONVERSION; VIRUS REACTIVATION;

CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84874116375     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0032-1333133     Document Type: Review

References (32)

1. Kenneson A., Cannon M. J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol: 2007; 17 253 276
2. Grosse S. D., Ross D. S., Dollard S. C. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol: 2008; 41 57 62
3. Centers for Disease Control and Prevention Congenital CMV trends and statistics. Available at: http://www.cdc.gov/cmv/trends-stats.html. Accessed December 21, 2012
4. Arvin A. M., Fast P., Myers M., Plotkin S., Rabinovich R. National Vaccine Advisory Committee Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis: 2004; 39 233 239
5. Cannon M. J., Davis K. F. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health: 2005; 5 70
6. Cahill A. G., Odibo A. O., Stamilio D. M., Macones G. A. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol: 2009; 201 e1 e7
7. Adler S. P. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol: 2011; 2011 1 9
8. Gaytant M. A., Steegers E. AP, Semmekrot B. A., Merkus H. M., Galama J. M. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv: 2002; 57 245 256
9. Staras S. AS, Dollard S. C., Radford K. W., Flanders W. D., Pass R. F., Cannon M. J. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis: 2006; 43 1143 1151
10. Stagno S., Pass R. F., Dworsky M. E., Alford C. A. Jr. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol: 1982; 25 563 576
11. Ludwig A., Hengel H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill: 2009; 14 26 32
12. Colugnati F. AF, Staras S. AS, Dollard S. C., Cannon M. J. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis: 2007; 7 71
13. Fowler K. B., Stagno S., Pass R. F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA: 2003; 289 1008 1011
14. Stagno S., Pass R. F., Cloud G., et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA: 1986; 256 1904 1908
15. Enders G., Daiminger A., Bäder U., Exler S., Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol: 2011; 52 244 246
16. Cannon M. J., Westbrook K., Levis D., Schleiss M. R., Thackeray R., Pass R. F. Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Prev Med: 2012; 54 351 357
17. Centers for Disease Control and Prevention Cytomegalovirus (CMV) and congenital CMV infection. At-risk patients. Available at: http://www.cdc.gov/ cmv/risk/infants-children.html. Accessed December 21, 2012
18. ACOG ACOG Practice Bulletin #20. Perinatal viral and parasitic infections. ACOG: 2011
19. Revello M. G., Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev: 2002; 15 680 715
20. Lazzarotto T., Guerra B., Lanari M., Gabrielli L., Landini M. P. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol: 2008; 41 192 197
21. Maidji E., McDonagh S., Genbacev O., Tabata T., Pereira L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol: 2006; 168 1210 1226
22. Dollard S. C., Staras S. AS, Amin M. M., Schmid D. S., Cannon M. J. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol: 2011; 18 1895 1899
23. Centers for Disease Control and Prevention Cytomegalovirus (CMV) and congenital CMV infection. Testing and diagnosis of CMV infection. Available at: http://www.cdc.gov/cmv/testing-diagnosis.html. Accessed December 21, 2012
24. Centers for Disease Control and Prevention Cytomegalovirus (CMV) and congenital CMV infection. Preventing congenital CMV infection. Available at: http://www.cdc.gov/cmv/prevention.html. Accessed December 21, 2012
25. Maine G. T., Stricker R., Schuler M., et al. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol: 2000; 38 1476 1481
26. Lazzarotto T., Galli C., Pulvirenti R., et al. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol: 2001; 8 196 198
27. Revello M. G., Genini E., Gorini G., Klersy C., Piralla A., Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol: 2010; 48 255 259
28. Adler S. P., Finney J. W., Manganello A. M., Best A. M. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis J: 1996; 15 240 246
29. Adler S. P., Finney J. W., Manganello A. M., Best A. M. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr: 2004; 145 485 491
30. Picone O., Vauloup-Fellous C., Cordier A. G., et al. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG: 2009; 116 818 823
31. Nigro G., Adler S. P., La Torre R., Best A. M. Congenital Cytomegalovirus Collaborating Group Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med: 2005; 353 1350 1362
32. Adler S. P. Editorial commentary: primary maternal cytomegalovirus infection during pregnancy: do we have a treatment option? Clin Infect Dis: 2012; 55 504 506